Copyright © 2002 by the European Society of Cardiology.
Editorials
Statins and mortality
a Department of Internal Medicine, University Hospital of Zürich, Switzerland
b Institute of Social and Preventive Medicine, University of Zürich, Switzerland
References
- Simes J, Furberg CD, Braunwald E. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels: the Prospective Pravastatin Pooling project. Eur Heart J. 2002;23:207215
[Abstract/Free Full Text] - Sacks FM, Pfeffer MA, Moye LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:10011009
[Abstract/Free Full Text] - N Engl J Med. 1998;339:13491357
[Abstract/Free Full Text] - Shepherd J, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:13011307
[Abstract/Free Full Text] - Lancet. 1994;344:13831389[CrossRef][ISI][Medline]
- Downs JR, Clearfield M, Weis S. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:16151622
[Abstract/Free Full Text] - Sacks FM, Tonkin AM, Shepherd J. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation. 2000;102:18931900
[Abstract/Free Full Text] - Merz CN, Rozanski A, Forrester JS. The secondary prevention of coronary artery disease. Am J Med. 1997;102:572581[CrossRef][ISI][Medline]
- Lotufo PA, Gaziano JM, Chae CU. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161:242247
[Abstract/Free Full Text] - Lancet. 2001;357:9951001[CrossRef][ISI][Medline]
- Eur Heart J. 1998;19:14341503
[Free Full Text] - JAMA. 2001;285:24862497
[Free Full Text]
This article has been cited by other articles:
![]() |
Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
